Next |
home / stock / cmpx / cmpx message board
Subject | By | Source | When |
---|---|---|---|
Compass to review latest phase 2 progress with | marketmanallm | investorshub | 12/21/2022 6:51:49 PM |
Reminder $CMPX is Compass Therapeutics ,,,EF Hutton new | marketmanallm | investorshub | 12/16/2022 2:42:53 PM |
https://www.streetinsider.com/Corporate+News/Compass+Therapeutics%2C+Inc+%28CMPX | marketmanallm | investorshub | 12/01/2022 3:23:52 PM |
amazing no one posts on any $CMPX boards | marketmanallm | investorshub | 11/12/2022 4:23:59 PM |
The proper company name associated with $CMPX symbol | marketmanallm | investorshub | 10/21/2022 2:33:36 PM |
Do you think they like their company ...a little?? | marketmanallm | investorshub | 09/27/2022 3:57:47 PM |
dude WTF!!!! another ALLM | NO birds Allowed | investorshub | 09/26/2022 7:09:02 PM |
is eh CEO still buying? | NO birds Allowed | investorshub | 09/21/2022 2:35:46 PM |
The relative outperformance continues stock sits at 3.05 | marketmanallm | investorshub | 08/25/2022 5:45:18 PM |
CEO continues to buy stock buys another 15000 | marketmanallm | investorshub | 08/18/2022 12:21:35 PM |
Now we're talking !! | marketmanallm | investorshub | 08/15/2022 11:10:51 AM |
Could the rocket be on the launching pad | marketmanallm | investorshub | 07/06/2022 8:04:39 PM |
Awaiting further data on CTX 009 and | marketmanallm | investorshub | 06/27/2022 1:42:39 PM |
I forgot to ask, have you or brooklyn | NO birds Allowed | investorshub | 06/08/2022 12:40:14 PM |
you must have guessed by now that we | NO birds Allowed | investorshub | 06/08/2022 12:35:26 PM |
hello old friend, this looks so much better | NO birds Allowed | investorshub | 06/06/2022 3:42:36 PM |
To present at Jefferies H/C conf. june 9th...will | marketmanallm | investorshub | 06/01/2022 3:39:40 PM |
CEO buys 60,000 more on 5/28 | marketmanallm | investorshub | 05/30/2022 1:49:35 PM |
Still amazed no posts on any stock | marketmanallm | investorshub | 05/21/2022 12:50:01 PM |
B of A health conf went great | marketmanallm | investorshub | 05/16/2022 3:46:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Compass Therapeutics Inc. Company Name:
CMPX Stock Symbol:
OTCMKTS Market:
Compass Therapeutics Inc. Website:
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside cha...
BOSTON, May 28, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its Board of Directors has appointed Thomas Sc...
CTX-471, a novel anti-CD137 agonist antibody, demonstrated anti-tumor activity in the Company’s Phase 1 Dose Escalation and Dose Expansion, first-in-human monotherapy study in patients with metastatic or locally advanced malignancies who had progressed on approved PD-1 or PD-L1 inhibitors....